CTMS platforms do not lack capability. They reflect an earlier architectural priority. The post Transforming CTMS: An Operating Layer for Real-Time Trial Execution appeared first on MedCity News.
Payment friction isn’t always obvious. It shows up in extended accounts receivable timelines, increased billing inquiries, and patients who delay payment – not because they’re unwilling to pay, but because the process made it harder than it needed to be. The post Patient Responsibility Is Rising — The Payment Experience Needs to Keep Up appeared…
Healthcare often expects consumers to contort themselves around processes that were never built with them in mind — and that’s where the trust issue begins. With the looming arrival of HR1, how to fix it. The post Lack of Trust, Not Technology, is What’s Stopping Health Plans from Meeting Their Mission and Financial Objectives appeared…
A handful of corporate hospital systems now dominate most U.S. hospital care, leading to higher prices for consumers
Next time you go to the pharmacy, you might be offered a coupon on your prescription drugs. While it may sound like a great deal — with the prospect of saving hundreds of dollars — the decision to accept it is complicated, especially for people with insurance. Even as prescription drug costs rise, patients with…
Since his second term started, President Donald Trump has announced, negotiated, or floated a flurry of initiatives aimed at taming the excesses of the pharmaceutical industry. No surprise. About 60% of American adults are “worried about being able to afford prescription drug costs for themselves or their families,” a recent KFF nationwide poll showed. More…
By MIKE MAGEE In its final summary of the landmark paper in Nature this past month, the authors led with this statement: “This study underscores the highly personalized nature of thymic health and emphasizes the previously unrecognized possible critical role of maintaining thymic health to preserve an agile, adaptive immune response that will accommodate long-term…
Stuart Figueroa provides some insights in his Incidental Economist article: To start, price shopping is inconvenient. It requires the consumer to invest time and energy in finding a provider, oftentimes having to navigate provider directories that are inaccurate, incomplete, or outdated. Price shopping is also hampered by the mere fact that health insurance is complicated and…
Lawmakers are applying increased scrutiny to private equity’s involvement in healthcare, particularly when it comes to physician practice roll-ups. But investor Matthew Bennett argues the pressure is reshaping rather than shrinking the sector, pushing firms away from roll-ups and toward strategies focused on improving outcomes and using technology to boost efficiency. The post How PE…
Perfuse Therapeutics brings Bayer an eye drug administered via an implant that controls the release of the therapy. This program is in mid-stage clinical development for glaucoma and diabetic retinopathy. The post Bayer Sees Opportunity With $300M Acquisition of Eye Drug Biotech appeared first on MedCity News.